Finn
BA Aerospace and Defense · Large cap · Industrial · Turnaround · Thesis updated August 5, 2026

Boeing has backlog, but execution decides the stock

01 Running thesis

A recovery still on trial

Boeing is one of the two main makers of large commercial airplanes. That market position is hard to copy. Airlines still need planes, and Boeing ended Q2 2026 with a record backlog of $715.3 billion. That gives the company a long runway of future work.

The near-term case is improving, but it is not clean. In Q2 2026, Boeing delivered 171 commercial airplanes and generated positive free cash flow of $631 million. The FAA also authorized Boeing to resume issuing airworthiness certificates. The 737 line is ramping to 47 planes per month by summer 2026.

The stock still depends on proof, not promises. Supply chain constraints are an ongoing bottleneck, with 787 engine delivery shortfalls requiring a recovery plan with GE. The 737-7 and 737-10 are still awaiting certification in 2026. The 777-9 first delivery is also pushed to 2027, and defense contracts continue to face charges, like the $280 million loss on the VC-25B program in Q2 2026.

Finn maintains a balanced but cautious view. Boeing has a deep order book and a stronger cash path than last year. But its valuation and financial health leave little room for another major mistake.

Jul 2026The Q2 2026 update showed positive momentum with 171 commercial deliveries and positive free cash flow of $631 million. However, a $280 million charge on the VC-25B program and 787 engine delays kept execution risks in focus.
Apr 2026The Q1 2026 call kept the thesis steady. Management repeated the 737 ramp plan, 737-7 and 737-10 certification timing, 777-9 first delivery in 2027, and $1B to $3B free cash flow guide.
Apr 2026The Q1 2026 10-Q showed better cash use, with operating cash outflow narrowing to $0.2B from $1.6B a year earlier. That helped confidence in near-term stabilization.
Jan 2026The 2025 10-K confirmed a major 777X setback, including a $4.9B reach-forward loss and first 777-9 delivery moving to 2027. It also added labor risk from SPEEA contracts expiring in October 2026.
Jan 2026The Q4 2025 call showed 737 production stabilizing at 42 planes per month and introduced 2026 free cash flow guidance of $1B to $3B. A $565 million KC-46A loss kept defense execution risk in view.
Oct 2025Boeing pushed expected 777-9 first delivery to 2027 and took a large charge. Progress on the 737 ramp helped, but the wide-body delay showed that program risk was still serious.
02 Business model

Big planes, long cycles, service cash

Boeing makes money by selling high-value aircraft and defense systems to airlines, leasing companies, and governments. These are long-cycle sales. A customer can order years before Boeing delivers the product and collects much of the cash.

The business has three main parts. Commercial Airplanes builds jets like the 737, 767, 777, and 787. Defense, Space and Security sells military aircraft, helicopters, tankers, satellites, and space systems. Global Services sells parts, maintenance, and analytics to support aircraft already in use.

Services matter because they are steadier and more profitable than new aircraft builds. In Q2 2026, Global Services had an 18.1 percent operating margin, much higher than the company average. That installed base helps soften the ups and downs of new aircraft production.

Boeing also acquired Spirit AeroSystems, a key supplier. The goal is tighter control over quality and production flow. That could help, but it also means Boeing now owns more of the problems if the supply chain struggles.

03 Product portfolio

What Boeing sells

Growth engine

737 family

The 737 is Boeing’s main narrow-body jet family and the core of the commercial recovery. The current watch point is the production ramp to 47 planes per month in summer 2026.

Steady

787 Dreamliner

The 787 is a wide-body jet used on long routes. Production relies on resolving supply chain issues, notably engine delivery shortfalls that required a recovery plan with GE.

Option

777X and 777-9

The 777X is Boeing’s next major wide-body program. First 777-9 delivery is now expected in 2027, making this a major test of certification and cost control.

Steady

Defense aircraft and systems

This segment includes products such as the F/A-18, F-15, P-8, KC-46A Tanker, Apache, Chinook, satellites, and space systems. It provides government-backed demand, but fixed-price programs can create losses when costs run high.

Cash cow

Global Services

Global Services sells parts, maintenance, and data services to commercial and defense customers. In Q2 2026 it produced $5.3B of revenue and an 18.1 percent operating margin.

Option

Spirit AeroSystems integration

Bringing Spirit in-house is meant to improve quality and supply stability. It could help the 737 supply chain, but integration adds work during an already tight recovery.

04 Business segments

Q2 2026 revenue mix

Commercial Airplanes48%modest
Defense, Space & Security30%flat
Global Services22%modest

The mix uses Q2 2026 segment revenue: $11.8B from Commercial Airplanes, $7.5B from Defense, Space and Security, and $5.3B from Global Services, out of $24.6B total revenue. Commercial Airplanes remains the largest driver as deliveries accelerate.

05 Risk factors

What could still break

737 ramp or certification slips

High impact · Medium odds

The 737 is central to Boeing’s cash recovery. Management plans to reach 47 planes per month by summer 2026, while the 737-7 and 737-10 are expected to be certified in 2026. If either slips, cash flow and customer confidence could weaken.

We watchFAA approval for the 737 rate increase and formal 737-7 and 737-10 certification in 2026.

777-9 cost and delivery risk

High impact · Medium odds

Boeing delayed first 777-9 delivery to 2027 and recorded a $4.9B reach-forward loss in 2025. Management says the delay is tied to certification work. Even so, another delay could create more customer claims, production costs, or charges.

We watchFAA certification flight test progress and any change to the first 777-9 delivery date.

787 supply chain friction

Medium impact · Medium odds

The 787 is part of the wide-body cash story, but Q2 2026 deliveries were affected by engine delivery shortfalls from GE. Boeing had to pause production temporarily. Failing to resolve these constraints would signal that production stability is not fully back.

We watchQuarterly 787 deliveries and updates on the GE engine recovery plan.

Fixed-price defense losses

Medium impact · Medium odds

Boeing’s defense unit recorded a new $280 million reach-forward loss on the VC-25B program in Q2 2026. Fixed-price contracts can hurt margins because Boeing must absorb extra costs after signing the deal.

We watchNew charges or catch-up adjustments on VC-25B, KC-46A, and other fixed-price development programs.

SPEEA labor talks

High impact · Medium odds

Contracts covering about 16,000 employees represented by SPEEA expire in October 2026. These workers include engineers and technical staff who matter to certification and production quality. A work stoppage could slow the recovery right as Boeing tries to raise output.

We watchProgress on SPEEA contract talks before the October 2026 expiration.
06 Quick answers

In one breath

Is Boeing a growth stock or a turnaround stock?

Right now it looks more like a turnaround stock. The backlog supports future growth, but investors still need proof that production, certification, and cash flow are getting better.

Why does Boeing’s backlog matter?

Backlog is the value of orders Boeing has not yet delivered. Boeing’s Q2 2026 backlog of $715.3 billion gives strong revenue visibility, but it only turns into cash if Boeing builds and delivers the products on time.

What is the biggest near-term milestone for Boeing?

The 737 production ramp is the biggest near-term test. Boeing plans to ramp production to 47 planes per month by summer 2026, progressing toward 52 per month.

Why is Finn cautious on Boeing?

Boeing has a strong market position and a record backlog, but its recent history includes certification delays, program charges, and weak financial health. The recovery can work, but the company has to execute without another major setback.

Get started with Finn today